You are here: All Products  > Yabao Gains China Rights to Stroke Treatment from Primary Peptides

Yabao Gains China Rights to Stroke Treatment from Primary Peptides

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products